The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Androgenic Alopecia Therapeutics Market Research Report 2025
Synopsis
Androgenic Alopecia refers to the phenomenon of hair loss, including natural hair loss and pathological hair loss caused by various reasons.
The global Androgenic Alopecia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Androgenic Alopecia Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Androgenic Alopecia Therapeutics include Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories and Concert Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Androgenic Alopecia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgenic Alopecia Therapeutics.
Report Scope
The Androgenic Alopecia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgenic Alopecia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgenic Alopecia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgenic Alopecia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Androgenic Alopecia refers to the phenomenon of hair loss, including natural hair loss and pathological hair loss caused by various reasons.
The global Androgenic Alopecia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Androgenic Alopecia Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Androgenic Alopecia Therapeutics include Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories and Concert Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Androgenic Alopecia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgenic Alopecia Therapeutics.
Report Scope
The Androgenic Alopecia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgenic Alopecia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgenic Alopecia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgenic Alopecia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgenic Alopecia Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgenic Alopecia Therapeutics Market Perspective (2019-2030)
2.2 Androgenic Alopecia Therapeutics Growth Trends by Region
2.2.1 Global Androgenic Alopecia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgenic Alopecia Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Androgenic Alopecia Therapeutics Market Dynamics
2.3.1 Androgenic Alopecia Therapeutics Industry Trends
2.3.2 Androgenic Alopecia Therapeutics Market Drivers
2.3.3 Androgenic Alopecia Therapeutics Market Challenges
2.3.4 Androgenic Alopecia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue
3.1.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue
3.4 Global Androgenic Alopecia Therapeutics Market Concentration Ratio
3.4.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2023
3.5 Androgenic Alopecia Therapeutics Key Players Head office and Area Served
3.6 Key Players Androgenic Alopecia Therapeutics Product Solution and Service
3.7 Date of Enter into Androgenic Alopecia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgenic Alopecia Therapeutics Breakdown Data by Type
4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030)
5 Androgenic Alopecia Therapeutics Breakdown Data by Application
5.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgenic Alopecia Therapeutics Market Size (2019-2030)
6.2 North America Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
6.4 North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Androgenic Alopecia Therapeutics Market Size (2019-2030)
7.2 Europe Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
7.4 Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Androgenic Alopecia Therapeutics Market Size (2019-2030)
9.2 Latin America Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Androgenic Alopecia Therapeutics Introduction
11.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.2.5 Merck Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction
11.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Cipla
11.5.1 Cipla Company Detail
11.5.2 Cipla Business Overview
11.5.3 Cipla Androgenic Alopecia Therapeutics Introduction
11.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.5.5 Cipla Recent Development
11.6 Almirall
11.6.1 Almirall Company Detail
11.6.2 Almirall Business Overview
11.6.3 Almirall Androgenic Alopecia Therapeutics Introduction
11.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.6.5 Almirall Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction
11.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 Reddy's Laboratories
11.8.1 Reddy's Laboratories Company Detail
11.8.2 Reddy's Laboratories Business Overview
11.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Introduction
11.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.8.5 Reddy's Laboratories Recent Development
11.9 Concert Pharmaceuticals
11.9.1 Concert Pharmaceuticals Company Detail
11.9.2 Concert Pharmaceuticals Business Overview
11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction
11.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.9.5 Concert Pharmaceuticals Recent Development
11.10 RiverTown Therapeutics
11.10.1 RiverTown Therapeutics Company Detail
11.10.2 RiverTown Therapeutics Business Overview
11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction
11.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.10.5 RiverTown Therapeutics Recent Development
11.11 Brickell Biotech
11.11.1 Brickell Biotech Company Detail
11.11.2 Brickell Biotech Business Overview
11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction
11.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.11.5 Brickell Biotech Recent Development
11.12 BiologicsMD
11.12.1 BiologicsMD Company Detail
11.12.2 BiologicsMD Business Overview
11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction
11.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.12.5 BiologicsMD Recent Development
11.13 Aclaris Therapeutics
11.13.1 Aclaris Therapeutics Company Detail
11.13.2 Aclaris Therapeutics Business Overview
11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction
11.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.13.5 Aclaris Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Androgenic Alopecia Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Androgenic Alopecia Therapeutics Market Share by Region (2019-2024)
Table 9. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Androgenic Alopecia Therapeutics Market Share by Region (2025-2030)
Table 11. Androgenic Alopecia Therapeutics Market Trends
Table 12. Androgenic Alopecia Therapeutics Market Drivers
Table 13. Androgenic Alopecia Therapeutics Market Challenges
Table 14. Androgenic Alopecia Therapeutics Market Restraints
Table 15. Global Androgenic Alopecia Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Androgenic Alopecia Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)
Table 18. Ranking of Global Top Androgenic Alopecia Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Androgenic Alopecia Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgenic Alopecia Therapeutics Product Solution and Service
Table 22. Date of Enter into Androgenic Alopecia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Androgenic Alopecia Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Johnson & Johnson Company Detail
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Androgenic Alopecia Therapeutics Product
Table 50. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Androgenic Alopecia Therapeutics Product
Table 55. Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Androgenic Alopecia Therapeutics Product
Table 60. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Astellas Pharma Company Detail
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Androgenic Alopecia Therapeutics Product
Table 65. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Astellas Pharma Recent Development
Table 67. Cipla Company Detail
Table 68. Cipla Business Overview
Table 69. Cipla Androgenic Alopecia Therapeutics Product
Table 70. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Cipla Recent Development
Table 72. Almirall Company Detail
Table 73. Almirall Business Overview
Table 74. Almirall Androgenic Alopecia Therapeutics Product
Table 75. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Almirall Recent Development
Table 77. Sun Pharma Company Detail
Table 78. Sun Pharma Business Overview
Table 79. Sun Pharma Androgenic Alopecia Therapeutics Product
Table 80. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Sun Pharma Recent Development
Table 82. Reddy's Laboratories Company Detail
Table 83. Reddy's Laboratories Business Overview
Table 84. Reddy's Laboratories Androgenic Alopecia Therapeutics Product
Table 85. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Reddy's Laboratories Recent Development
Table 87. Concert Pharmaceuticals Company Detail
Table 88. Concert Pharmaceuticals Business Overview
Table 89. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product
Table 90. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Concert Pharmaceuticals Recent Development
Table 92. RiverTown Therapeutics Company Detail
Table 93. RiverTown Therapeutics Business Overview
Table 94. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product
Table 95. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 96. RiverTown Therapeutics Recent Development
Table 97. Brickell Biotech Company Detail
Table 98. Brickell Biotech Business Overview
Table 99. Brickell Biotech Androgenic Alopecia Therapeutics Product
Table 100. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 101. Brickell Biotech Recent Development
Table 102. BiologicsMD Company Detail
Table 103. BiologicsMD Business Overview
Table 104. BiologicsMD Androgenic Alopecia Therapeutics Product
Table 105. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 106. BiologicsMD Recent Development
Table 107. Aclaris Therapeutics Company Detail
Table 108. Aclaris Therapeutics Business Overview
Table 109. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product
Table 110. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
Table 111. Aclaris Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgenic Alopecia Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Androgenic Alopecia Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Androgenic Alopecia Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Androgenic Alopecia Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Androgenic Alopecia Therapeutics Report Years Considered
Figure 12. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Androgenic Alopecia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Androgenic Alopecia Therapeutics Market Share by Players in 2023
Figure 16. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2023
Figure 18. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Region (2019-2030)
Figure 32. China Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 49. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 50. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 51. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 52. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 53. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 54. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 55. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 56. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 57. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 58. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
